Increased fat content in the pancreas in obese children and adolescents is associated with a number of cardiometabolic risks.
A woman who took creatine for 100 days has shared all the benefits she experienced and how it changed her life ...
April is National Donate Life Month, a time set aside to recognize organ donors and the people whose lives have been changed ...
12hon MSN
Low energy, poor sleep, weight gain? Doctors explain early metabolic decline, and how to fix it
The body rarely fails suddenly. Instead, organs slow down together in a phase called early metabolic decline. The good news ...
The health ministry warns that GLP-1 drugs for Type 2 Diabetes and obesity should only be taken under medical supervision due ...
If you’ve been struggling with unstable blood sugar, sudden energy crashes, or unexplained weight gain, Gluco6 might ...
The U.S. Food and Drug Administration has approved Eli Lilly’s new weight-loss GLP-1 pill, orforglipron, which will be sold ...
Recent research shows that tumors in different organs host microbial communities capable of influencing cancer biology, immune responses, and the effectiveness of therapies, highlighting the need to ...
AngioDynamics, Inc. ( ANGO) Q3 2026 Earnings Call April 2, 2026 8:00 AM EDT Good morning, and welcome to the AngioDynamics Fiscal Year 2026 Third Quarter Earnings Call. [Operator Instructions] As a ...
In an era where blood-sugar supplements flood the market with exaggerated promises, Gluco Armor stands out for an ...
Newsable Asianet News on MSN
GLP-1 drugs for diabetes: India details use, risks, and regulation
The Indian government has released details on GLP-1 drugs for diabetes and obesity, explaining their function and risks. Amid concerns over unsupervised use, the Drug Controller of India has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results